Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Chrysalis Investments announces successful sale of Graphcore to SoftBank Chrysalis Investments Limited (Chrysalis) has confirmed the sale of its stake in Graphcore to SoftBank Group Corp., a… byPallavi MadhirajuJuly 14, 2024